Author:
Arango D,Wilson A J,Shi Q,Corner G A,Arañes M J,Nicholas C,Lesser M,Mariadason J M,Augenlicht L H
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Andre T, Bensmaine MA, Louvet C, Francois E, Lucas V, Desseigne F, Beerblock K, Bouche O, Carola E, Merrouche Y, Morvan F, Dupont-Andre G, de Gramont A (1999) Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen. J Clin Oncol 17: 3560–3568
2. Arango D, Augenlicht LH (2001) New approaches to colorectal cancer treatment. In Recent Research Developments in Cancer Pandalal SG (ed). Vol 3, pp 385–395. Trivandrum: Transworld Research Network
3. Arango D, Corner GA, Wadler S, Catalano PJ, Augenlicht LH (2001) c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo. Cancer Res 61: 4910–4915
4. Arango D, Mariadason JM, Willson AJ, Yang W, Corner GA, Arañes MJ, Nicholas C, Augenlicht LH (2003) c-Myc overexpression sensitizes colon cancer cells to camptothecin-induced apoptosis. Br J Cancer 89: 1757–1765
5. Arnould S, Hennebelle I, Canal P, Bugat R, Guichard S (2003) Cellular determinants of oxaliplatin sensitivity in colon cancer cell lines. Eur J Cancer 39: 112–119
Cited by
214 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献